Gland Pharma Share Price Target 2022, 2023, 2024, 2025, 2030
Gland Pharma Share Price Target 2022, 2023, 2024, 2025, 2030: The company was incorporated as Gland Pharma Private Limited, a limited company, at Hyderabad in 1956 and received a certificate of incorporation from the Registrar of Companies, Andhra Pradesh at Hyderabad.
So in this article we try to give Gland Pharma Share a new way through technical and fundamental analysis.
Gland Pharma Share Price Target 2022
The name of the company was changed to Gland Pharma Limited by a special resolution passed by the shareholders of the company in 1994 and a new memorandum of association was issued in 1995 by the Registrar of Companies, Andhra Pradesh at Hyderabad as a result of the change of name and conversion into a limited company in 1956. is one of the fastest growing generic injectables companies by revenue in the United States from 2014 to 2019. It primarily sells its products under the brand name Business Model in many countries including the United States, Europe, Canada, Australia, India and the rest of the world.
The stock price target for Gland Pharma will be available by the end of financial year 2022. The initial price of Gland Pharma will be around Rs 2700. And the second target budget price of Gland Pharma will be Rs 2800.
| Year | Gland Pharma Share Price Target 2022 |
|---|---|
| First Target 2022 | Rs 2700 |
| Second Target 2022 | Rs 2800 |
Also read:- Trigyn Technologies Share Price Target 2022, 2023, 2024, 2025, 2030
Gland Pharma Share Price Target 2023
Gland Pharma has a consistent track record in compliance with a range of regulatory regimes across these markets. He also has extensive experience in the development, manufacture and marketing of complex injectable products and a good understanding of the sophisticated scientific, technical and regulatory processes involved. Founded in Hyderabad, India in 1978, it has expanded from liquid parenterals to other elements of the injectables value chain, including contract development, in-house development, documentation preparation and archiving, technology transfer and manufacturing across a range of application systems.
Gland Pharma Share Price Target by the end of 2023, The target value of Gland Pharma First Share for the financial year 2023 is estimated to be Rs 3200. And the second share price Target of Gland Pharma Could offer around Rs 3350.
| Year | Gland Pharma Share Price Target 2023 |
|---|---|
| First Target 2023 | Rs 3200 |
| Second Target 2023 | Rs 3200 |
Also read:- Lloyds Steel Share Price Target 2022, 2023, 2024, 2025, 2030
Gland Pharma Share Price Target 2024
Gland Pharma has a professional management team and one of its promoters, Shanghai Fosun Pharma, is a global pharmaceutical company. The company focuses on meeting diverse needs in the field of injectables with a stable supply of affordable and high quality products. It has established a portfolio of injectable products in various therapeutic areas and application systems. It is present in sterile injectables, oncology and ophthalmology and focuses on complex injectable applications. Its delivery systems include liquid vials, lyophilized vials, prefilled syringes, ampoules, sachets and drops.
At this time we try to predict the price of two Gland Pharma which will be available in 2024. The first target price of Gland Pharma is Rs 3800. And Gland Pharma’s second price target could cross Rs 4000.
| Year | Gland Pharma Share Price Target 2024 |
|---|---|
| First Target 2024 | Rs 3800 |
| Second Target 2024 | Rs 4000 |
Also read:- Biogen Pharmachem Share Price Target 2022, 2023, 2024, 2025, 2030
Gland Pharma Share Price Target 2025
Gland Pharma has expanded its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products, as well as new delivery systems such as pens and cartridges. Gland Pharma has launched Bortezomib for Injection, 3.5 mg/vial, single-dose vial in the US through its partner. It is bioequivalent and therapeutically equivalent to the reference drug (RLD), Velcade for Injection, 3.5 mg/vial from Takeda Pharmaceuticals U.S.A., Inc. Bortezomib for injection is used to treat certain types of cancer, such as multiple myeloma and mantle cell lymphoma.
Gland Pharma two share price targets for FY 2025, Gland Pharma first share price target in FY 2025 will be Rs 4500. And the second FY2025 price target for Gland Pharma will be around Rs 4800.
| Year | Gland Pharma Share Price Target 2025 |
|---|---|
| First Target 2025 | Rs 4500 |
| Second Target 2025 | Rs 4800 |
Also read:- Avanti Feeds Share Price Target 2022, 2023, 2024, 2025, 2030
Gland Pharma Share Price Target 2030
Gland Pharma is engaged in complex injectables, contract development and biosimilars manufacturing to drive near-term growth. The Company has made good progress in R&D with respect to the planned submission of doses of complex injectables to be administered in the current financial year. The company is on track to complete four complex injections this financial year. In the near future, the company is focusing on creating a strong portfolio of complex injectable preparations. It also looks at acquisition opportunities that will help accelerate the development process. The installation of new lines for the administration of suspensions and hormonal preparations was completed.
The target price for Gland Pharma shares will be available by the end of financial year 2030. The price of the first share of Gland Pharma will be Rs 8500. And the second price target of Gland Pharma stock will be Rs 9000 by the end of the financial year 2030.
| Year | Gland Pharma Share Price Target 2030 |
|---|---|
| First Target 2030 | Rs 8500 |
| Second Target 2030 | Rs 9000 |
Also read:- Meghmani Organics Share Price Target 2022, 2023, 2024, 2025, 2030
Future Prospectus of Gland Pharma Share
- Gland Pharma is engaged in complex injectables, contract development and biosimilars manufacturing to drive near-term growth.
- Gland Pharma has expanded its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products, as well as new delivery systems such as pens and cartridges.
Gland Pharma Share Price Target 2022, 2023, 2024, 2025, 2030 Table
| Year | Gland Pharma Share Price Target |
|---|---|
| First Target 2022 | Rs 2700 |
| Second Target 2022 | Rs 2800 |
| First Target 2023 | Rs 3200 |
| Second Target 2023 | Rs 3350 |
| First Target 2024 | Rs 3800 |
| Second Target 2024 | Rs 4000 |
| First Target 2025 | Rs 4500 |
| Second Target 2025 | Rs 4800 |
| First Target 2030 | Rs 8500 |
| Second Target 2030 | Rs 9000 |
Risk of Gland Pharma Share
- Gland Pharma needs additional funding to realize its full potential across the industry, otherwise Gland Pharma will not be able to provide benefits or returns to its investors for years to come.
- Gland Pharma has a very high debt to the company that needs to be reduced in the coming years or any sales or income they generate annually will be used to cover their debts.
Expert Views on Gland Pharma Share
With all the features related to Gland Pharma, we can say that you should watch this stock for some time and I would say that you need to wait some time before investing in Gland Pharma stock.
Gland Pharma Share F.A.Q.
– Where is Gland Pharma’s headquarters located?
Gland Pharma is headquartered in Hyderabad.
– Who is the current MD of Gland Pharma?
The current MD of Gland Pharma is Shanghai Fosun.
– In Which business does Gland Pharma participate?
Gland Pharma develops, manufactures and sells complex injectable preparations. The company sells its products in many countries mainly according to the business-to-business model.
I hope that after reading the article Gland Pharma Share Price Target 2022, 2023, 2024, 2025, 2030 you must have got a good idea what kind of performance can be seen in the growth of the Company. If you still have any question related to this article in your mind, then do not forget to tell in the comment at all. Stay tuned to Market in India for important information about this type of stock in the stock market.
Also read:-
